# Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer

> **NCT00174863** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 232 (actual)

## Conditions studied

- Prostatic Neoplasm

## Interventions

- **DRUG:** SR31747A

## Key facts

- **NCT ID:** NCT00174863
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2008-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174863, "Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00174863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*